Fulgent Genetics, Inc. (FLGT)
21.48
+0.18
(+0.85%)
USD |
NASDAQ |
Oct 02, 16:00
21.50
+0.02
(+0.09%)
Pre-Market: 20:00
Fulgent Genetics Max Drawdown (5Y) : 91.69% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 91.69% |
| August 31, 2026 | 91.69% |
| July 31, 2026 | 91.69% |
| June 30, 2026 | 91.69% |
| May 31, 2026 | 91.69% |
| April 30, 2026 | 91.69% |
| March 31, 2026 | 91.69% |
| February 28, 2026 | 91.69% |
| January 31, 2026 | 91.69% |
| December 31, 2025 | 91.69% |
| November 30, 2025 | 91.69% |
| October 31, 2025 | 91.69% |
| September 30, 2025 | 91.69% |
| August 31, 2025 | 91.69% |
| July 31, 2025 | 91.69% |
| June 30, 2025 | 91.69% |
| May 31, 2025 | 91.69% |
| April 30, 2025 | 91.69% |
| March 31, 2025 | 91.69% |
| February 28, 2025 | 91.60% |
| January 31, 2025 | 90.95% |
| December 31, 2024 | 90.91% |
| November 30, 2024 | 90.91% |
| October 31, 2024 | 89.62% |
| September 30, 2024 | 89.62% |
| Date | Value |
|---|---|
| August 31, 2024 | 89.62% |
| July 31, 2024 | 89.62% |
| June 30, 2024 | 89.62% |
| May 31, 2024 | 89.11% |
| April 30, 2024 | 89.11% |
| March 31, 2024 | 88.28% |
| February 29, 2024 | 87.73% |
| January 31, 2024 | 87.14% |
| December 31, 2023 | 87.14% |
| November 30, 2023 | 87.14% |
| October 31, 2023 | 87.14% |
| September 30, 2023 | 85.46% |
| August 31, 2023 | 84.49% |
| July 31, 2023 | 84.49% |
| June 30, 2023 | 84.49% |
| May 31, 2023 | 84.49% |
| April 30, 2023 | 84.28% |
| March 31, 2023 | 84.10% |
| February 28, 2023 | 84.10% |
| January 31, 2023 | 84.10% |
| December 31, 2022 | 84.10% |
| November 30, 2022 | 81.49% |
| October 31, 2022 | 80.30% |
| September 30, 2022 | 79.37% |
| August 31, 2022 | 77.98% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Quest Diagnostics, Inc. | 28.60% |
| Labcorp Holdings, Inc. | 34.60% |
| OPKO Health, Inc. | 85.55% |
| Psychemedics Corp. | 87.72% |
| NeoGenomics, Inc. | 91.92% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -37.67 |
| Beta (5Y) | 0.9347 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 43.87% |
| Historical Sharpe Ratio (5Y) | -0.6455 |
| Historical Sortino (5Y) | -1.020 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 18.96% |